Back to Search
Start Over
Design, Synthesis, and Evaluation of New Quinazolinone Derivatives that Inhibit Bloom Syndrome Protein (BLM) Helicase, Trigger DNA Damage at the Telomere Region, and Synergize with PARP Inhibitors
- Source :
- Journal of Medicinal Chemistry; September 2020, Vol. 63 Issue: 17 p9752-9772, 21p
- Publication Year :
- 2020
-
Abstract
- DNA damage response (DDR) pathways are crucial for the survival of cancer cells and are attractive targets for cancer therapy. Bloom syndrome protein (BLM) is a DNA helicase that performs important roles in DDR pathways. Our previous study discovered an effective new BLM inhibitor with a quinazolinone scaffold by a screening assay. Herein, to better understand the structure–activity relationship (SAR) and biological roles of the BLM inhibitor, a series of new derivatives were designed, synthesized, and evaluated based on this scaffold. Among them, compound 9hexhibited nanomolar inhibitory activity and binding affinity for BLM. 9hcould effectively disrupt BLM recruitment to DNA in cells. Furthermore, 9hinhibited the proliferation of the colorectal cell line HCT116 by significantly triggering DNA damage in the telomere region and inducing apoptosis, especially in combination with a poly (ADP-ribose) polymerase (PARP) inhibitor. This result suggested a synthetic lethal effect between the BLM and PARP inhibitors in DDR pathways.
Details
- Language :
- English
- ISSN :
- 00222623 and 15204804
- Volume :
- 63
- Issue :
- 17
- Database :
- Supplemental Index
- Journal :
- Journal of Medicinal Chemistry
- Publication Type :
- Periodical
- Accession number :
- ejs53847645
- Full Text :
- https://doi.org/10.1021/acs.jmedchem.0c00917